Sequenom Paces Gainers as GWDN Index Rises 3 Percent in November | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom, Myriad Genetics, and Affymetrix saw their respective stocks gain more than 20 percent in value during November to lead the GenomeWeb Daily News Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.